In the dynamic realm of life sciences, mergers and acquisitions (M&A) serve as pivotal strategies for companies aiming to expand their research capabilities, diversify product lines, and enhance market presence. Central to the success of these transactions is the thorough analysis of patent portfolios, which represent the intellectual backbone